About us
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
Calliditas’ lead product, developed under the name Nefecon, has been granted accelerated approval by the FDA under the trade name TARPEYO® and conditional marketing authorization by the European Commission under the trade name KINPEYGO®.
TARPEYO and KINPEYGO® are the first and only treatments approved for IgA nephropathy by the FDA and EMA, respectively.
Calliditas also has a pipeline in orphan-focused indications. Calliditas is conducting a Phase 2b/3 clinical trial in primary biliary cholangitis and a Phase 2 proof-of-concept trial in head and neck cancer with its NOX inhibitor product candidate, setanaxib.
Calliditas’ common shares are listed on Nasdaq Stockholm (ticker:
CALTX) and its American Depositary Shares are listed on the Nasdaq
Global Select Market (ticker: CALT).
Position summary
The Regional Business Director is responsible for the development and performance of all sales activities in an assigned market. This position staffs and directs a regional sales team and provides leadership towards the achievement of maximum profitability and growth in line with the company vision and values. The RBD will need to observe and identify market opportunities and challenges and subsequently develop, plan, implement, and follow through with action plans to positively influence opportunities and challenges within and through their team; this includes the development of team members towards corporate growth. The RBD will report to the Head of US Sales.
Key tasks and responsibilities
Education and experience requirements
Reasons to join the Calliditas Team
Welcome to join the Calliditas Team!
Ameriprise Financial Services, LLC
Agios Pharmaceuticals
Glooko
Takeda
Yale Realty & Capital Advisors